Patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC)

Abstract Stereotactic body radiotherapy (SBRT) applies high doses and requires advanced techniques to spare surrounding tissue in the presence of organ motion. In this work patient individual phase gating is investigated. We studied peripheral and central primary lung tumors. The internal target vol...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: K. M. Kraus, M. Oechsner, J. J. Wilkens, K. A. Kessel, S. Münch, S. E. Combs
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a3eb53e756c64862a665a4a1c30cdbcb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a3eb53e756c64862a665a4a1c30cdbcb
record_format dspace
spelling oai:doaj.org-article:a3eb53e756c64862a665a4a1c30cdbcb2021-12-02T11:36:21ZPatient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC)10.1038/s41598-021-85031-w2045-2322https://doaj.org/article/a3eb53e756c64862a665a4a1c30cdbcb2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-85031-whttps://doaj.org/toc/2045-2322Abstract Stereotactic body radiotherapy (SBRT) applies high doses and requires advanced techniques to spare surrounding tissue in the presence of organ motion. In this work patient individual phase gating is investigated. We studied peripheral and central primary lung tumors. The internal target volume (ITV) was defined including different numbers of phases picked from a 4D Computed tomography (CT) defining the gating window (gw). Planning target volume (PTV) reductions depending on the gw were analyzed. A treatment plan was calculated on a reference phase CT (rCT) and the dose for each breathing phase was calculated and accumulated on the rCT. We compared the dosimetric results with the dose calculated when all breathing phases were included for ITV definition. GWs including 1 to 10 breathing phases were analyzed. We found PTV reductions up to 38.4%. The mean reduction of the lung volume receiving 20 Gy due to gating was found to be 25.7% for peripheral tumors and 16.7% for central tumors. Gating considerably reduced esophageal doses. However, we found that simple reduction of the gw does not necessarily influence the dose in a clinically relevant range. Thus, we suggest a patient individual definition of the breathing phases included within the gw.K. M. KrausM. OechsnerJ. J. WilkensK. A. KesselS. MünchS. E. CombsNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
K. M. Kraus
M. Oechsner
J. J. Wilkens
K. A. Kessel
S. Münch
S. E. Combs
Patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC)
description Abstract Stereotactic body radiotherapy (SBRT) applies high doses and requires advanced techniques to spare surrounding tissue in the presence of organ motion. In this work patient individual phase gating is investigated. We studied peripheral and central primary lung tumors. The internal target volume (ITV) was defined including different numbers of phases picked from a 4D Computed tomography (CT) defining the gating window (gw). Planning target volume (PTV) reductions depending on the gw were analyzed. A treatment plan was calculated on a reference phase CT (rCT) and the dose for each breathing phase was calculated and accumulated on the rCT. We compared the dosimetric results with the dose calculated when all breathing phases were included for ITV definition. GWs including 1 to 10 breathing phases were analyzed. We found PTV reductions up to 38.4%. The mean reduction of the lung volume receiving 20 Gy due to gating was found to be 25.7% for peripheral tumors and 16.7% for central tumors. Gating considerably reduced esophageal doses. However, we found that simple reduction of the gw does not necessarily influence the dose in a clinically relevant range. Thus, we suggest a patient individual definition of the breathing phases included within the gw.
format article
author K. M. Kraus
M. Oechsner
J. J. Wilkens
K. A. Kessel
S. Münch
S. E. Combs
author_facet K. M. Kraus
M. Oechsner
J. J. Wilkens
K. A. Kessel
S. Münch
S. E. Combs
author_sort K. M. Kraus
title Patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC)
title_short Patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC)
title_full Patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC)
title_fullStr Patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC)
title_full_unstemmed Patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC)
title_sort patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (nsclc)
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/a3eb53e756c64862a665a4a1c30cdbcb
work_keys_str_mv AT kmkraus patientindividualphasegatingforstereotacticradiationtherapyofearlystagenonsmallcelllungcancernsclc
AT moechsner patientindividualphasegatingforstereotacticradiationtherapyofearlystagenonsmallcelllungcancernsclc
AT jjwilkens patientindividualphasegatingforstereotacticradiationtherapyofearlystagenonsmallcelllungcancernsclc
AT kakessel patientindividualphasegatingforstereotacticradiationtherapyofearlystagenonsmallcelllungcancernsclc
AT smunch patientindividualphasegatingforstereotacticradiationtherapyofearlystagenonsmallcelllungcancernsclc
AT secombs patientindividualphasegatingforstereotacticradiationtherapyofearlystagenonsmallcelllungcancernsclc
_version_ 1718395778814181376